These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1598588)

  • 21. Induction of specific immune responses by polycation-based vaccines.
    Lührs P; Schmidt W; Kutil R; Buschle M; Wagner SN; Stingl G; Schneeberger A
    J Immunol; 2002 Nov; 169(9):5217-26. PubMed ID: 12391240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design of a complete synthetic peptide-based AIDS vaccine with a built-in adjuvant.
    Nardelli B; Defoort JP; Huang W; Tam JP
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1405-7. PubMed ID: 1466968
    [No Abstract]   [Full Text] [Related]  

  • 23. Adjuvant-Dependent Enhancement of HIV Env-Specific Antibody Responses in Infant Rhesus Macaques.
    Phillips B; Van Rompay KKA; Rodriguez-Nieves J; Lorin C; Koutsoukos M; Tomai M; Fox CB; Eudailey J; Dennis M; Alam SM; Hudgens M; Fouda G; Pollara J; Moody A; Shen X; Ferrari G; Permar S; De Paris K
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30089691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice.
    Magnusson SE; Altenburg AF; Bengtsson KL; Bosman F; de Vries RD; Rimmelzwaan GF; Stertman L
    Immunol Res; 2018 Apr; 66(2):224-233. PubMed ID: 29594879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein.
    Singh S; Yang G; Byrareddy SN; Barry MA; Sastry KJ
    Vaccine; 2014 Dec; 32(51):6934-6940. PubMed ID: 25444819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunization with an interferon-gamma-gp120 fusion protein induces enhanced immune responses to human immunodeficiency virus gp120.
    McCormick AL; Thomas MS; Heath AW
    J Infect Dis; 2001 Dec; 184(11):1423-30. PubMed ID: 11709784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting early events in T cell activation to construct improved vaccines.
    Buchan GS; Young SL; Lockhart EA; Wales J; Faulkner L; Slobbe L; Baird MA
    Mol Immunol; 2000 Jun; 37(9):545-52. PubMed ID: 11163404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF.
    Barouch DH; Santra S; Tenner-Racz K; Racz P; Kuroda MJ; Schmitz JE; Jackson SS; Lifton MA; Freed DC; Perry HC; Davies ME; Shiver JW; Letvin NL
    J Immunol; 2002 Jan; 168(2):562-8. PubMed ID: 11777947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potency of cell-mediated immune responses to different combined HIV-1 immunogens in a humanized murine model.
    Azizi A; Ghorbani M; Kryworuchko M; Aucoin S; Diaz-Mitoma F
    Hum Vaccin; 2005; 1(4):170-6. PubMed ID: 17012859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.
    BenMohamed L; Gras-Masse H; Tartar A; Daubersies P; Brahimi K; Bossus M; Thomas A; Druilhe P
    Eur J Immunol; 1997 May; 27(5):1242-53. PubMed ID: 9174617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of HIV-1 envelope (gp120)-specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell-derived gp120 is enhanced by enzymatic removal of N-linked glycans.
    Doe B; Steimer KS; Walker CM
    Eur J Immunol; 1994 Oct; 24(10):2369-76. PubMed ID: 7523139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enzymatic labeling of biologically active envelope glycoprotein gp120 of HIV-1.
    Berkower I; Murphy D
    Biochem Biophys Res Commun; 1993 Mar; 191(3):1055-65. PubMed ID: 8466484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA fusion vaccine designed to induce cytotoxic T cell responses against defined peptide motifs: implications for cancer vaccines.
    Rice J; Elliott T; Buchan S; Stevenson FK
    J Immunol; 2001 Aug; 167(3):1558-65. PubMed ID: 11466377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. E2 multimeric scaffold for vaccine formulation: immune response by intranasal delivery and transcriptome profile of E2-pulsed dendritic cells.
    Trovato M; Maurano F; D'Apice L; Costa V; Sartorius R; Cuccaro F; McBurney SP; Krebs SJ; Prisco A; Ciccodicola A; Rossi M; Haigwood NL; De Berardinis P
    BMC Microbiol; 2016 Jul; 16(1):152. PubMed ID: 27421762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased immunogenicity of human immunodeficiency virus gp120 engineered to express Galalpha1-3Galbeta1-4GlcNAc-R epitopes.
    Abdel-Motal U; Wang S; Lu S; Wigglesworth K; Galili U
    J Virol; 2006 Jul; 80(14):6943-51. PubMed ID: 16809300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of gp120-specific immune responses by genetic vaccination with the human immunodeficiency virus type 1 envelope gene fused to the gene coding for soluble CTLA4.
    Nayak BP; Sailaja G; Jabbar AM
    J Virol; 2003 Oct; 77(20):10850-61. PubMed ID: 14512535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity.
    Belyakov IM; Moss B; Strober W; Berzofsky JA
    Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4512-7. PubMed ID: 10200293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional equivalency of B7-1 and B7-2 for costimulating plasmid DNA vaccine-elicited CTL responses.
    Santra S; Barouch DH; Jackson SS; Kuroda MJ; Schmitz JE; Lifton MA; Sharpe AH; Letvin NL
    J Immunol; 2000 Dec; 165(12):6791-5. PubMed ID: 11120800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthetic peptides representing discontinuous CD4 binding epitopes of HIV-1 gp120 that induce T cell apoptosis and block cell death induced by gp120.
    Howie SE; Cotton GJ; Heslop I; Martin NJ; Harrison DJ; Ramage R
    FASEB J; 1998 Aug; 12(11):991-8. PubMed ID: 9707171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of immune responses induced by HIV-1 gp120 in rhesus macaques: effect of vaccination on challenge with pathogenic strains of homologous and heterologous simian human immunodeficiency viruses.
    Kumar A; Lifson JD; Silverstein PS; Jia F; Sheffer D; Li Z; Narayan O
    Virology; 2000 Aug; 274(1):149-64. PubMed ID: 10936096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.